Further complicating the issue, these conversations often happen above the patient, leaving gaps in the flow of information, and patients with more questions than answers.
The analysis only uses U.S. revenue estimates generated from TG-1101 in relapsed and refractory NHL and CLL patient populations, as well as its current cash flow position.
Sprouse and others theorized in the early 1990s that drugs that blocked these self-defeating autoreceptors could create a faster impact by causing an immediate, long-lasting flow of serotonin that would lift a patient's mood in days.